News and Publications

Below you can find a summary of HIFU in the news. You can read the full story by clicking on the "Details" link following the summary.

More and more men are facing a medical conundrum: Either risk losing your sex life forever, or travel abroad for a $25,000 procedure that the FDA hasn’t approved yet.

The sheer number of available prostate-cancer treatments—there are six mainstream options—initially bewildered Bowman, and, like many newly diagnosed men, he spent weeks studying the voluminous and contentious literature on the subject. “I worked day and night,” he recalls, “but I never seemed to get tired. I felt like I was in a war, fighting for my life. And just like war, there was the fog: too much information.” He obsessively surfed Web sites, interviewed a range of urologists, and discovered that, invariably, each one recommended his own pet procedure.Featured in Best Life Magazine.
Click Here for Details

Focus Surgery, Inc. the developer of the Sonablate® 500, announced today that the Food and Drug Administration (FDA) granted the Sonablate® 500 a provisional Investigational Device Exemption (IDE), which will allow the device to be used in a multicenter clinical study to collect safety and efficacy data for final FDA approval. The clinical study will use High Intensity Focused Ultrasound (HIFU) for the treatment of low risk, localized (T1c/T2a) prostate cancer with the Sonablate® 500. The study will enroll approximately 466 subjects at 24 institutions.
Click Here for Details

One of the options Charles Edgington's doctor presented after diagnosing him with prostate cancer included flying to Puerto Vallarta to have the disease annihilated by a robotic ultrasonic probe that heated his prostate to 212 degrees. The options did include confiscating the whole walnut-looking gland all together, or freezing it with cryotherapy, or radiating it externally.....
Click Here for Details

Have Questions?